These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22388692)

  • 1. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
    Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
    Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
    J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
    Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
    Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
    Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
    J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
    Tchu SM; Lynch KL; Wu AH
    Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
    Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
    Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.
    Maximov PY; McDaniel RE; Fernandes DJ; Bhatta P; Korostyshevskiy VR; Curpan RF; Jordan VC
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25258390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of antitumor tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen to human serum albumin.
    Bourassa P; Dubeau S; Maharvi GM; Fauq AH; Thomas TJ; Tajmir-Riahi HA
    Biochimie; 2011 Jul; 93(7):1089-101. PubMed ID: 21439346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locating the binding sites of anticancer tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen on bovine serum albumin.
    Bourassa P; Dubeau S; Maharvi GM; Fauq AH; Thomas TJ; Tajmir-Riahi HA
    Eur J Med Chem; 2011 Sep; 46(9):4344-53. PubMed ID: 21777996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.
    Ximenez JPB; de Andrade JM; Marques MP; Coelho EB; Suarez-Kurtz G; Lanchote VL
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):81. PubMed ID: 31852530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
    Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
    Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locating the binding sites of antitumor drug tamoxifen and its metabolites with DNA.
    Bourassa P; Thomas TJ; Tajmir-Riahi HA
    J Pharm Biomed Anal; 2014 Jul; 95():193-9. PubMed ID: 24682017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.
    de Vries Schultink AH; Alexi X; van Werkhoven E; Madlensky L; Natarajan L; Flatt SW; Zwart W; Linn SC; Parker BA; Wu AH; Pierce JP; Huitema AD; Beijnen JH
    Breast Cancer Res Treat; 2017 Feb; 161(3):567-574. PubMed ID: 28005246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on the association of tamoxifen, endoxifen, and 4-hydroxytamoxifen with blood lipids in patients with breast cancer.
    Siqueira MLS; Andrade SMV; Vieira JLF; Monteiro MC
    Biomed Pharmacother; 2021 Oct; 142():111972. PubMed ID: 34391185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
    J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.